By Professor Matthew Gwyn Law

Journal articles

Losso MH; Belloso WH; Emery S; Benetucci JA; Cahn PE; Lasala MC; Lopardo G; Salomon H; Saracco M; Nelson E; Law MG; Davey RC; Allende MC; Lane HC; And TVSG, 2000, 'A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts ? 350/mm³', Journal of Infectious Diseases, 181, pp. 1614 - 1621

Carr AD; Mills J; Law MG; Cooper DA, 2000, 'A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome', AIDS, 14, pp. 25 - 32

Grulich AE; Wan X; Law MG; Milliken ST; Lewis CR; Garsia R; Gold J; Finlayson R; Kaldor JM, 2000, 'B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin¿s lymphoma in people with AIDS', AIDS, 14, pp. 133 - 140

Smith DE; Goggin L; Meldrum H; Phillips S; Russell-Weisz D; Bloch M; Bodsworth NJ; Roth N; Law MG, 2000, 'Capturing the paradigm shift in HIV treatment: changing attitudes in the choice of combination antiretroviral drugs by high HIV caseload Australian GPs (1996-1997)', AIDS Care - Psychological and Socio - Medical Aspects of AIDS/HIV, 12, pp. 41 - 47

Law MG; Li Y; McDonald AM; Cooper DA; Kaldor JM, 2000, 'Estimating the population impact in Australia of improved antiretroviral treatment for HIV infection', AIDS, 14, pp. 197 - 201

Mills J; Carr AD; Smith DE; Emery S; Law MG; Grey PA; Cooper DA, 2000, 'Lipodystrophy following antiretroviral therapy of primary HIV infection (letter)', AIDS, 14, pp. 2406 - 2407

Law MG; Roberts S; Dore GJ; Kaldor JM, 2000, 'Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality', Medical Journal of Australia, 173, pp. 403 - 405

Law MG, 2000, 'Problems with publishing results of interim analyses of randomized clinical trials', HIV Clinical Trials, 1, pp. 30 - 36

Correll PK; Law MG; McDonald AM; Cooper DA; Kaldor JM, 1999, 'HIV disease progression in Australia in the time of combination antiretroviral therapies', MEDICAL JOURNAL OF AUSTRALIA, 170, pp. 285 - 285, http://dx.doi.org/10.5694/j.1326-5377.1999.tb127767.x

Haylen BT; Law MG; Frazer M; Schulz S, 1999, 'Urine flow rates and residual urine volumes in urogynecology patients', International Urogynecology Journal, 10, pp. 378 - 383, http://dx.doi.org/10.1007/s001920050064

Law MG; De Winter L; McDonald AM; Cooper DA; Kaldor JM, 1999, 'AIDS-diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment', AIDS, 13, pp. 263 - 269

Correll PK; Law MG; McDonald AM; Cooper DA; Kaldor JM, 1999, 'HIV disease progression in Australia in the time of combination antiretroviral therapies. (Author's reply)', Medical Journal of Australia, 170, pp. 285 - 285 (letter)

Kaufmann GR; Cunningham PH; Zaunders J; Law MG; Vizzard J; Carr AD; Cooper DA, 1999, 'Impact of early HIV-1 RNA and T-lymphocyte dynamics during primary HIV-1 infection on the subsequent course of HIV-1 RNA levels and CD4+ T-lymphocyte counts in the first year of HIV-1 infection', Journal of acquired immune deficiency syndrome and human retrovirology, pp. 437 - 444

Kaufmann GR; Cunningham P; Zaunders J; Law M; Vizzard J; Carr A; Cooper DA, 1999, 'Impact of Early HIV-1 RNA and T-Lymphocyte Dynamics During Primary HIV-1 Infection on the Subsequent Course of HIV-1 RNA Levels and CD4+ T-Lymphocyte Counts in the First Year of HIV-1 Infection', Journal of Acquired Immune Deficiency Syndromes, 22, pp. 437 - 437, http://dx.doi.org/10.1097/00042560-199912150-00003

Law MG; On BOTHC, 1999, 'Modelling the hepatitis C virus epidemic in Australia', Journal of Gastroenterol Hepatol, 14, pp. 1100 - 1107

Freund J; Carr A; Samaras K; Law M; Chisholm DJ; Cooper DA; Griffiths MR; Majerovic Y; Noakes KA, 1999, 'Peripheral lipodystrophy measured by DEXA in patients receiving HIV protease inhibitors', Nuclear Medicine Communications, 20, pp. 390 - 390, http://dx.doi.org/10.1097/00006231-199904000-00104

Dore GJ; Law MG; Kaldor JM, 1999, 'Prevalence of hepatitis C virus infection in the United States', New England Journal of Medicine, pp. 2093 - 2094 (lett

Grulich AE; Wan X; Law MG; Coates ML; Kaldor JM, 1999, 'Risk of cancer in people with AIDS', AIDS, 13, pp. 839 - 843

Collins SL; Law MG; Fletcher A; Boyd AW; Kaldor JM; Masters C, 1999, 'Surgical treatment and risk of sporadic Creutzfeldt-Jacob disease: a case-control study', The Lancet, pp. 693 - 697

Benson EM; Clarkson J; Law MG; Marshall ; Kelleher AD; Smith DE; Patou G; Stewart GA; Cooper DA; French FA, 1999, 'Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific CTL activity in asymptomatic HIV infected individuals.', AIDS Research and Human Retroviruses, 15, pp. 105 - 113

Law MG; Anderson JS; Cui JS; Duncombe CJ; Mallal SS; Roth N; Fagan D; Smith DE; Bloch M; Grulich AE, 1999, 'Trends in antiretroviral treatment for people with HIV in Australia: an observational database pilot study', Venereology - the Interdisciplinary International Journal of Sexual Health, 12, pp. 97 - 103

Links MJ; Watson SR; Lethlean K; Aherne W; Kirsten F; Clarke SP; Law MG; Friedlander ML; Galettis P; Mckeage M, 1999, 'Vinblastine pharmacokinetics in patients with non-small cell lung cancer given cisplatin', Cancer Investigation, 17, pp. 479 - 485

Dore GJ; Pritchard-Jones J; Fisher D; Law MG, 1999, 'Who's at risk: risk factors for HCV infection in Australia', Australian Family Physician, pp. 8 - 13

Hales G; Mitchell J; Druett J; Law M; Roth N; Smith D, 1998, 'A randomised trial of three combination therapies which enhance saquinavir levels', AIDS, 12, pp. S37 - S37, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000077311300142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Moorey S; Greer S; Bliss J; Law M, 1998, 'A comparison of adjuvant psychological therapy and supportive counselling in patients with cancer', Psycho-Oncology, 7, pp. 218 - 228, http://dx.doi.org/10.1002/(SICI)1099-1611(199805/06)7:3<218::AID-PON308>3.0.CO;2-D

Carr AD; Samaras K; Burton S; Law MG; Freund J; Chisholm DJ; Cooper DA, 1998, 'A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors', AIDS, 12, pp. F51 - F58

Law MG; McDonald AM; Menzies R, 1998, 'Changes in reporting of HIV diagnoses in Australia', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, pp. 161 - 161

Crofts JN; Dore GJ; Kaldor JM; Law MG; Wodak AD; Et A, 1998, 'Estimates and projections of the hepatitis C virus epidemic in Australia', ION Meeting Proceedings

Chandeying V; Skov S; Kemapunmanus M; Law MG; Geater A; Rowe PB, 1998, 'Evaluation of two clinical protocols for the management of women with vaginal discharge in southern Thailand', Sexually Transmitted Diseases, pp. 194 - 201

Correll PK; Law MG; McDonald AM; Cooper DA; Kaldor JM, 1998, 'HIV disease progression in Australia in the time of combination antiretroviral therapies', Medical Journal of Australia, 169, pp. 469 - 472

Dore GJ; Grulich AE; Law MG; Brew BJ; Kaldor JM, 1998, 'Kaposi¿s sarcoma and protection from AIDS dementia complex', AIDS, 12, pp. 2354 - 2355

Law MG; McDonald AM; Menzies R, 1998, 'New numbers on HIV diagnoses in Australia', Australian HIV Surveillance Report, 14, pp. 9 - 10

Law MG; McDonald AM; Menzies R, 1998, 'New numbers on HIV diagnoses in Australia', Noah's Arc, pp. 65 - 65

Kaufmann GR; Cunningham PH; Kelleher AD; Zaunders J; Carr AD; Vizzard J; Law MG; Cooper DA; Catchpole BR; Baker D; Beveridge A; Bloch M; Byrne J; Doong N; Duncombe CJ; Finlayson R; Genn W; Kidd J; Mcfarlane R; Mcmurchie M; Mcnulty A; Pethebridge A; Quan D; Robertson M, 1998, 'Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection', Journal of Infectious Diseases, 178, pp. 1812 - 1815

Ashton LJ; Carr AD; Cunningham PH; Roggensack M; Mclean K; Law MG; Robertson M; Cooper DA; Kaldor JM, 1998, 'Predictors of progression in long-term nonprogressors.', AIDS Research and Human Retroviruses, 14, pp. 117 - 121

Lord RS; Law MG; Ward RL; Giles G; Thomas R; Thursfield V, 1998, 'Rising incidence of oesophageal adenocarcinoma in men in Australia.', Journal of Gastroenterology and Hepatology, 13, pp. 356 - 362

Grulich A; Wan X; Law M; Milliken S; Lewis C; Garsia R; Gold J; Finlayson R; Cooper DA; Kaldor JM, 1998, 'RISK FACTORS FOR AIDS ASSOCIATED NON-HODGKIN'S LYMPHOMA: A CASE-CONTROL STUDY.', Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 17, pp. A39 - A39, http://dx.doi.org/10.1097/00042560-199804010-00127

Law MG, 1998, 'The hepatitis C virus projections working group', Noah's Arc, pp. 25 - 26

Law MG; Downs AM; Brunet J; Kaldor JM, 1998, 'Time trends in HIV infection among pregnant women in Europe', AIDS, 12, pp. 211 - 216

Law MG; Bartos M; Goddard M, 1998, 'Uptake of antiretroviral treatments in Australia', Australian HIV Surveillance Report, 14, pp. 1 - 4

Aguado JM; Pulido F; Dore GJ; Law MG; Kaldor JM; Gordin F; Matts J, 1997, 'Isoniazid prophylaxis for high-risk patients with anergy and HIV infection [4] (multiple letters)', New England Journal of Medicine, 337, pp. 1696 - 1697, http://dx.doi.org/10.1056/NEJM199712043372316

Dore GJ; Law MG; Kaldor JM, 1997, 'Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.', The New England journal of medicine, 337, pp. 1697

Law MG; Kaldor JM, 1997, 'Survival analysis of randomized clinical trials adjusted for patients who switch treatments - Reply', STATISTICS IN MEDICINE, 16, pp. 2620 - 2621, http://dx.doi.org/10.1002/(SICI)1097-0258(19971130)16:22<2620::AID-SIM1699>3.0.CO;2-4

Porter K; Law MG; Kaldor JM; Lepri AC; Phillips AN; Pezzotti P; Rezza G; Sinicco A; Fora R; Raiteri R; Sciandra M; Bechis G; Calvo MM; Gioannini P, 1997, 'Is the clinical course of HIV infection changing?', BMJ, 315, pp. 1236, http://dx.doi.org/10.1136/bmj.315.7117.1236a

Law MG; Kaldor JM, 1997, 'Is the clinical course of HIV infection changing? Exclusion of people not followed up for 12 months may have biased results.', BMJ (Clinical research ed.), 315, pp. 1236 - 1237

Huddart RA; Rajan B; Law M; Meyer L; Dearnaley DP, 1997, 'Spinal cord compression in prostate cancer: Treatment outcome and prognostic factors', Radiotherapy and Oncology, 44, pp. 229 - 236, http://dx.doi.org/10.1016/S0167-8140(97)00112-6

Dore GJ; Law MG; Brew BJ, 1997, 'Prospective analysis of seizures occurring in human immunodeficiency virus type-1 infection', Journal of Neuro-AIDS, 1, pp. 59 - 69, http://dx.doi.org/10.1300/J128v01n04_06

Tait DM; Nahum AE; Meyer LC; Law M; Dearnaley DP; Horwich A; Mayles WP; Yarnold JR, 1997, 'Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment', Radiotherapy and Oncology, 42, pp. 121 - 135, http://dx.doi.org/10.1016/S0167-8140(96)01870-1

Yiangou C; Gomm JJ; Coope RC; Law M; Luqmani YA; Shousha S; Coombes RC; Johnston CL, 1997, 'Fibroblast growth factor 2 in breast cancer: Occurrence and prognostic significance', British Journal of Cancer, 75, pp. 28 - 33, http://dx.doi.org/10.1038/bjc.1997.5

Dore GJ; Law MG; Kaldor JM, 1997, 'A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis', New England Journal of Medicine, pp. 315 - 320

Back to profile page